Arrowhead Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
08.08.25
/
50%
€14.10
Target price
08.08.26
€32.59
Performance (%)
20.99%
Price
22:26
€17.06
Summary
This prediction is currently active. The prediction currently has a performance of 20.99%. This prediction currently runs until 08.08.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Arrowhead Pharmaceuticals Inc. | 24.291% |
| iShares Core DAX® | 0.648% |
| iShares Nasdaq 100 | -0.034% |
| iShares Nikkei 225® | 2.445% |
| iShares S&P 500 | 0.492% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its price target lowered by analysts at Royal Bank Of Canada from $40.00 to $38.00. They now have an "outperform" rating on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.89
11.02.25
11.02.25
€40.58
11.02.26
11.02.26
-4.64%
22:26
22:26
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.62
26.09.24
26.09.24
€37.69
26.09.25
26.09.25
-3.15%
22:26
22:26
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€29.40
07.02.24
07.02.24
€46.44
07.02.25
07.02.25
-32.70%
08.02.25
08.02.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€31.94
16.01.24
16.01.24
€45.92
16.01.25
16.01.25
-41.56%
17.01.25
17.01.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€22.00
30.11.23
30.11.23
€45.85
30.11.24
30.11.24
11.32%
01.12.24
01.12.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.07
08.08.23
08.08.23
€54.74
08.08.24
08.08.24
-10.25%
09.08.24
09.08.24